Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More
  • Fund Family BlackRock
  • Assets Under Management 8,732,592,000
  • Shares Outstanding, K 81,400

Price Performance

See More
Period Period Low Period High Performance
1-Month
100.43 +7.10%
on 05/03/18
108.48 -0.85%
on 05/14/18
+4.30 (+4.16%)
since 04/25/18
3-Month
100.22 +7.32%
on 04/06/18
115.60 -6.96%
on 03/13/18
-3.12 (-2.82%)
since 02/23/18
52-Week
94.20 +14.18%
on 05/31/17
119.30 -9.84%
on 01/29/18
+10.72 (+11.07%)
since 05/25/17

Most Recent Stories

More News
Should You Invest in the PowerShares Dynamic Biotechnology & Genome Portfolio (PBE)?

Sector ETF report for PBE

PBE : 50.65 (-0.78%)
ILMN : 266.22 (-1.70%)
IBB : 107.56 (+0.20%)
QGEN : 36.26 (-0.06%)
XBI : 93.00 (+0.29%)
BIIB : 286.21 (+0.63%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 33.92 (+0.34%)
CNCR : 28.35 (+0.25%)
IBB : 107.56 (+0.20%)
PSCH : 124.18 (+0.15%)
XBI : 93.00 (+0.29%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 33.92 (+0.34%)
CNCR : 28.35 (+0.25%)
IBB : 107.56 (+0.20%)
PSCH : 124.18 (+0.15%)
XBI : 93.00 (+0.29%)
Is PowerShares Dynamic Biotechnology & Genome Portfolio (PBE) a Hot ETF Right Now?

Smart Beta ETF report for PBE

PBE : 50.65 (-0.78%)
ILMN : 266.22 (-1.70%)
IBB : 107.56 (+0.20%)
VRTX : 157.50 (+0.34%)
REGN : 293.74 (-0.30%)
XBI : 93.00 (+0.29%)
Here's an ETF to Invest in Immunotherapy--the Game Changing Cancer Treatment

CNCR ETF is up about 30% this year; here is what investors need to know about immunotherapy and the ETF (CNCR, IBB).

CNCR : 28.35 (+0.25%)
IBB : 107.56 (+0.20%)
Stock Market News for March 5, 2018

Healthy rise in healthcare shares helped the S&P 500 and the Nasdaq finish in the positive territory on Friday

QVCA : 27.93 (+2.76%)
IBB : 107.56 (+0.20%)
PRGO : 75.24 (+0.17%)
Biotech ETFs Head to Head: XBI vs. IBB.

Head-to-head comparison of two Biotech ETFs, XBI and IBB.

CELG : 78.63 (-1.14%)
ARRY : 15.89 (+1.60%)
IBB : 107.56 (+0.20%)
BIVV : 104.98 (+0.32%)
GILD : 67.38 (-0.22%)
AMGN : 178.24 (+0.16%)
XBI : 93.00 (+0.29%)
JUNO : 86.96 (+0.10%)
Biotech ETFs Head to Head: XBI vs. IBB.

Head-to-head comparison of two Biotech ETFs, XBI and IBB.

CELG : 78.63 (-1.14%)
ARRY : 15.89 (+1.60%)
IBB : 107.56 (+0.20%)
BIVV : 104.98 (+0.32%)
GILD : 67.38 (-0.22%)
AMGN : 178.24 (+0.16%)
XBI : 93.00 (+0.29%)
JUNO : 86.96 (+0.10%)
3 ETFs to Watch on Biotech Earnings

Major Biotech companies report mixed Q4 results.

IBB : 107.56 (+0.20%)
BBH : 117.66 (+0.05%)
BIB : 54.94 (+0.33%)
GILD : 67.38 (-0.22%)
AMGN : 178.24 (+0.16%)
ALXN : 117.74 (+0.51%)
BIIB : 286.21 (+0.63%)
3 ETFs to Watch on Biotech Earnings

Major Biotech companies report mixed Q4 results.

IBB : 107.56 (+0.20%)
BBH : 117.66 (+0.05%)
BIB : 54.94 (+0.33%)
GILD : 67.38 (-0.22%)
AMGN : 178.24 (+0.16%)
ALXN : 117.74 (+0.51%)
BIIB : 286.21 (+0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade IBB with:

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

2nd Resistance Point 108.05
1st Resistance Point 107.81
Last Price 107.56
1st Support Level 107.29
2nd Support Level 107.01

See More

52-Week High 119.30
Fibonacci 61.8% 109.71
Last Price 107.56
Fibonacci 50% 106.75
Fibonacci 38.2% 103.79
52-Week Low 94.20

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar